Literature DB >> 23361876

CX3CL1/CX3CR1 regulates nerve injury-induced pain hypersensitivity through the ERK5 signaling pathway.

Jian-Liang Sun1, Chun Xiao, Bo Lu, Juan Zhang, Xiao-Zong Yuan, Wei Chen, Li-Na Yu, Feng-Jiang Zhang, Gang Chen, Min Yan.   

Abstract

Peripheral nerve injury induces the cleavage of CX3CL1 from the membrane of neurons, where the soluble CX3CL1 subsequently plays an important role in the transmission of nociceptive signals between neurons and microglia. Here we investigated whether CX3CL1 regulates microglia activation through the phosphorylation of extracellular signal-regulated protein kinase 5 (ERK5) in the spinal cord of rats with spinal nerve ligation (SNL). ERK5 and microglia were activated in the spinal cord after SNL. The knockdown of ERK5 by intrathecal injection of antisense oligonucleotides suppressed the hyperalgesia and nuclear impact of nuclear factor-κB induced by SNL. The blockage of CX3CR1, the receptor of CX3CL1, significantly reduced the level of ERK5 activation following SNL. In addition, the antisense knockdown of ERK5 reversed the CX3CL1-induced hyperalgesia and spinal microglia activation. Our study suggests that CX3CL1/CX3CR1 regulates nerve injury-induced pain hypersensitivity through the ERK5 signaling pathway.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23361876     DOI: 10.1002/jnr.23168

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  29 in total

Review 1.  Regulation of microglial activation in stroke.

Authors:  Shou-Cai Zhao; Ling-Song Ma; Zhao-Hu Chu; Heng Xu; Wen-Qian Wu; Fudong Liu
Journal:  Acta Pharmacol Sin       Date:  2017-03-06       Impact factor: 6.150

2.  Distinct terminal and cell body mechanisms in the nociceptor mediate hyperalgesic priming.

Authors:  Luiz F Ferrari; Dioneia Araldi; Jon D Levine
Journal:  J Neurosci       Date:  2015-04-15       Impact factor: 6.167

3.  Marked sexual dimorphism in 5-HT1 receptors mediating pronociceptive effects of sumatriptan.

Authors:  Dioneia Araldi; Luiz F Ferrari; Paul Green; Jon D Levine
Journal:  Neuroscience       Date:  2016-12-29       Impact factor: 3.590

4.  Second messengers mediating the expression of neuroplasticity in a model of chronic pain in the rat.

Authors:  Luiz F Ferrari; Oliver Bogen; Jon D Levine
Journal:  J Pain       Date:  2014-01-07       Impact factor: 5.820

5.  Mechanisms Mediating High-Molecular-Weight Hyaluronan-Induced Antihyperalgesia.

Authors:  Ivan J M Bonet; Dionéia Araldi; Eugen V Khomula; Oliver Bogen; Paul G Green; Jon D Levine
Journal:  J Neurosci       Date:  2020-07-14       Impact factor: 6.167

6.  CD44 Signaling Mediates High Molecular Weight Hyaluronan-Induced Antihyperalgesia.

Authors:  Luiz F Ferrari; Eugen V Khomula; Dioneia Araldi; Jon D Levine
Journal:  J Neurosci       Date:  2017-11-24       Impact factor: 6.167

7.  Role of Nociceptor Toll-like Receptor 4 (TLR4) in Opioid-Induced Hyperalgesia and Hyperalgesic Priming.

Authors:  Dioneia Araldi; Oliver Bogen; Paul G Green; Jon D Levine
Journal:  J Neurosci       Date:  2019-06-17       Impact factor: 6.167

8.  Fentanyl Induces Rapid Onset Hyperalgesic Priming: Type I at Peripheral and Type II at Central Nociceptor Terminals.

Authors:  Dioneia Araldi; Eugen V Khomula; Luiz F Ferrari; Jon D Levine
Journal:  J Neurosci       Date:  2018-02-05       Impact factor: 6.167

Review 9.  Research progress of the role and mechanism of extracellular signal-regulated protein kinase 5 (ERK5) pathway in pathological pain.

Authors:  Li-Na Yu; Li-Hong Sun; Min Wang; Min Yan
Journal:  J Zhejiang Univ Sci B       Date:  2016 Oct.       Impact factor: 3.066

Review 10.  Corneal pain and experimental model development.

Authors:  Tina B McKay; Yashar Seyed-Razavi; Chiara E Ghezzi; Gabriela Dieckmann; Thomas J F Nieland; Dana M Cairns; Rachel E Pollard; Pedram Hamrah; David L Kaplan
Journal:  Prog Retin Eye Res       Date:  2018-11-16       Impact factor: 21.198

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.